Last10K.com

Argenx Se (ARGX) SEC Filing 6-K Foreign Issuer report for the period ending Thursday, July 30, 2020

Argenx Se

HISTORY TOOLS
CIK: 1697862 Ticker: ARGX

View differences made from one to another to evaluate Argenx Se's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Argenx Se.

Continue

Assess how Argenx Se's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Argenx Se's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Argenx Se provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Ticker: ARGX
CIK: 1697862
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-20-088156
Submitted to the SEC: Thu Jul 30 2020 8:15:41 AM EST
Accepted by the SEC: Thu Jul 30 2020
Period: Thursday, July 30, 2020
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/argx/0001104659-20-088156.htm